2016年的制药行业。从分子类型角度对美国食品药品监督管理局药品批准情况的分析。

The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type.

作者信息

Torre Beatriz G de la, Albericio Fernando

机构信息

School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, 4001 Durban, South Africa.

School of Chemistry, University of KwaZulu-Natal, 4001 Durban, South Africa.

出版信息

Molecules. 2017 Feb 27;22(3):368. doi: 10.3390/molecules22030368.

DOI:10.3390/molecules22030368

PMID:28264468

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6155368/

Abstract

This is an analysis from a chemical point of view of the 22 drugs accepted by the FDA during 2016. The different drugs from the 2016 "harvest" have been classified according to their chemical structure: antibodies; TIDES (oligonucleotides and peptides); amino acids and natural products; drug combination; and small molecules.

摘要

这是从化学角度对2016年美国食品药品监督管理局（FDA）批准的22种药物进行的分析。2016年“收获”的不同药物已根据其化学结构进行了分类：抗体；TIDES（寡核苷酸和肽）；氨基酸和天然产物；药物组合；以及小分子。